Speakers

Ranjit Manchanda is a Professor at Wolfson Institute of Population Health (WIPH), Queen Mary University of London and leads the Women’s Precision Prevention Team. He co-Leads the Cancer Screening, Prevention and Epidemiology Unit at Centre for Cancer Screening, Prevention & Early Diagnosis in WIPH. He is a Consultant Gynaecological Oncologist at Barts Health NHS-Trust.

He holds an Honorary Professorship at the Department of Health Services Research, London School of Hygiene & Tropical Medicine. Ranjit’s main research interests are focused on Targeted Precision Prevention. He leads a number of studies across population-based genetic testing, mainstreaming genetic testing and precision medicine approaches for risk prediction, stratification, targeted screening and targeted cancer prevention, along with health economic issues related to these areas of research. He is an NHS Innovation Accelerator Alumnus, the Topic Advisor (Clinical Lead) for the NICE guideline NG241, co-Leads the SPED working-group of Lancet commission on Ovarian Cancer, and is a member of the ESGO Council.